Graham Number Checker

Date Checked2026-02-19 22:18:38
Graham Number(PB)2.97 vs (PE)0.00
Over / Under Value Percentage-30.07% vs 0.00%
Dividend Yield0.00%
Dividend DateNone
SymbolINO
AssetTypeCommon Stock
NameInovio Pharmaceuticals Inc
DescriptionInovio Pharmaceuticals Inc. is a pioneering biotechnology company focused on creating novel DNA-based therapeutics for various diseases, including cancer and infectious infections such as HPV. Utilizing its proprietary platform, Inovio is a leader in the immunotherapy sector, showcasing a robust pipeline of candidates aimed at addressing critical unmet medical needs. With ongoing clinical trials that underscore its commitment to scientific innovation, Inovio is strategically positioned to capitalize on emerging health challenges, suggesting strong potential for growth and sustained value creation in the biopharmaceutical industry.
CIK1055726
ExchangeNASDAQ
CurrencyUSD
CountryUSA
SectorHEALTHCARE
IndustryBIOTECHNOLOGY
Address660 WEST GERMANTOWN PIKE, PLYMOUTH MEETING, PA, UNITED STATES, 19462
OfficialSitehttps://www.inovio.com
FiscalYearEndDecember
LatestQuarter2025-09-30
MarketCapitalization110612000
EBITDA-88220528
PERatio0
PEGRatio0
BookValue-0.144
DividendPerShareNone
EPS-2.72
RevenuePerShareTTM0.005
ProfitMargin0
OperatingMarginTTM-492.03
ReturnOnAssetsTTM-0.636
ReturnOnEquityTTM-3.284
RevenueTTM182340
GrossProfitTTM-56648752
DilutedEPSTTM-2.72
QuarterlyEarningsGrowthYOY0
QuarterlyRevenueGrowthYOY0.14
AnalystTargetPrice7.63
AnalystRatingStrongBuy2
AnalystRatingBuy2
AnalystRatingHold2
AnalystRatingSell0
AnalystRatingStrongSell0
TrailingPE-
ForwardPE-
PriceToSalesRatioTTM606.64
PriceToBookRatio4.582
EVToRevenue405.58
EVToEBITDA-1.094
Beta1.626
52WeekHigh2.98
52WeekLow1.3
50DayMovingAverage2.076
200DayMovingAverage1.997
SharesOutstanding68703000
SharesFloat53348000
PercentInsiders0.395
PercentInstitutions37.971
ExDividendDateNone
dateChecked2026-02-19 22:18:38
fresh1